GlucoTrack Announces Successful Human Clinical Trial of CGM
Glucotrack, Inc. has successfully completed its first human clinical study of a continuous blood glucose monitor (CBGM) implanted in...
eClinical Tech News
FLT201 Gene Therapy Shows Promise in Gaucher Disease Trial
Spur Therapeutics released positive Phase 1/2 trial data for FLT201, a gene therapy for Gaucher disease type 1. The...
Aclaris Announces Fully Funded Clarity Trial for Nociscan
Aclarion, Inc. (Nasdaq: ACON, ACONW) has secured approximately $20 million to fully fund its pivotal CLARITY trial. This trial...
Nexalin’s Breakthrough DIFS™ Device Reduces Blood Pressure, Improves Mental Health
Nexalin Technology, Inc. announced positive results from a clinical study published in the Journal of Affective Disorders, showing its...
Tenaya Therapeutics Gets $8M Grant for Heart Failure Research
Tenaya Therapeutics received an $8 million grant from the California Institute for Regenerative Medicine (CIRM) to fund its Phase...
Seclidemstat and Azacitidine Trial for Hematologic Cancers Patient Enrollment Resumes
Salarius Pharmaceuticals (Nasdaq: SLRX) has announced the resumption of patient enrollment in a Phase 1/2 clinical trial at MD...
GH001 Meets Primary Endpoint in Phase 2b TRD Trial
GH Research PLC announced positive Phase 2b trial results for GH001, an inhalable mebufotenin treatment for treatment-resistant depression (TRD)....
Invivyd Announces Positive Phase 1/2 Data for VYD2311 for COVID-19
Invivyd announced positive Phase 1/2 clinical trial data for VYD2311, a monoclonal antibody designed to offer superior, long-lasting protection...
Cervomed Neflamapimod DLB Program Update at Lewy Body Dementia Conference
CervoMed provided an update on its Phase 2b RewinD-LB trial for neflamapimod in dementia with Lewy bodies (DLB). The...
Regulatory Review Update on Lecanemab for Early Alzheimer’s Disease in the EU
Eisai and Biogen provided an update on the European Union’s regulatory review of lecanemab, a treatment for early-stage Alzheimer’s...